Inventor
FAULKNER MARK C
US15 patents
⚠️ This page may combine multiple inventors who share the name “FAULKNER MARK C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VIREO SYSTEMS INC
14 patentsUS8962685B2Feb 24, 2015
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC11 citations92
US8354450B2Jan 15, 2013
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC22 citations92
US8026385B2Sep 27, 2011
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC15 citations92
US10342771B2Jul 9, 2019
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC3 citations83
US9962352B2May 8, 2018
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC4 citations83
US9486424B2Nov 8, 2016
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC7 citations83
US10881630B2Jan 5, 2021
Creatine oral supplementation using creatine hydrochloride salt
VIREO SYSTEMS INC1 citations72
US10583105B2Mar 10, 2020
Compositions and methods for neuroprotection and treatment of neurodegeneration
VIREO SYSTEMS INC1 citations69
US10245245B2Apr 2, 2019
Compositions and methods for neuroprotection and treatment of neurodegeneration
VIREO SYSTEMS INC2 citations69
US12564567B2Mar 3, 2026
Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus
VIREO SYSTEMS INC0 citations62
US11826334B2Nov 28, 2023
Antiviral therapeutic compounds and compositions for use in treatment of coronavirus and influenza virus
VIREO SYSTEMS INC0 citations62
US11160776B2Nov 2, 2021
Compositions and methods for neuroprotection and treatment of neurodegeneration
VIREO SYSTEMS INC0 citations59
US12109195B2Oct 8, 2024
Compositions and methods for treatment of vaginal infections
VIREO SYSTEMS INC0 citations53
US12011469B2Jun 18, 2024
Parenteral delivery device and methods of use
VIREO SYSTEMS INC0 citations53